**Core Concept**
Imipenem is a carbapenem antibiotic with a broad spectrum of activity against a wide range of Gram-positive and Gram-negative bacteria. Its mechanism of action involves inhibiting bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), ultimately leading to cell lysis and death.

**Why the Correct Answer is Right**
Imipenem is primarily excreted by the kidneys, and in patients with renal dysfunction, its clearance is reduced. This can lead to increased levels of imipenem and its dehydropeptidase-1 (DHP-1) metabolite, cilastatin. The accumulation of these compounds can cause seizures, a well-documented side effect of imipenem. To prevent this, dosage adjustments are necessary in patients with renal impairment, making option C the most accurate statement.

**Why Each Wrong Option is Incorrect**
**Option A:** Imipenem has a broad spectrum of antibacterial action, not a narrow one. It is effective against a wide range of pathogens, including both Gram-positive and Gram-negative bacteria.
**Option B:** Imipenem is not used in a fixed-dose combination with sulbactam. Sulbactam is a beta-lactamase inhibitor that is often combined with ampicillin or other penicillins to enhance their antibacterial activity.
**Option D:** Imipenem is not effective against methicillin-resistant Staphylococcus aureus (MRSA). While it has a broad spectrum of activity, its efficacy against MRSA is limited.

**Clinical Pearl / High-Yield Fact**
In patients with renal impairment, it's essential to carefully monitor imipenem levels and adjust dosages accordingly to prevent seizures. This highlights the importance of individualizing drug therapy based on a patient's renal function.

**✓ Correct Answer: C. In renal dysfunction, dosage reductions are necessary to avoid seizures**